When was MediWound founded?

MediWound was founded in 2001 and raised its 1st funding round 12 years after it was founded.

Where is MediWound located?

MediWound is headquartered in Yavne, Israel. It is registered at 16 CHARLOTTE SQUARE,EDINBURGH,MIDLOTHIAN,EH2 4DF.

How many employees does MediWound have?

As of May 31, 2026, the latest employee count at MediWound is 119.

Is MediWound a funded company?

MediWound is a funded company, having raised a total of $18M across 6 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Jun 23, 2013.

When was the latest funding round of MediWound?

MediWound's latest funding was a $***** Grant (prize money) round on Jul 16, 2024, with participation from 1 investor.

Where does MediWound rank among its competitors?

MediWound ranks 6th amongst 206 active competitors, of which 45 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was BioStem Technologies, which secured $2.5M in May, 2026.

Who are the top competitors of MediWound?

MediWound's top competitors include SolasCure, SanuWave and Nuo Therapeutics. Among them, BioStem Technologies secured the most recent funding round in May, 2026.

MediWound - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of enzymatic therapeutic solutions for tissue repair and regeneration. It leverages enzymatic technology to develop active therapies for burn, wound care, and biological medicinal products for tissue repair. The product portfolio includes NexoBrid, EscharEx, and MW005, topical enzymatic therapy for the treatment of non-melanoma skin cancers.

Website: mediwound.com
Registered Address: 16 CHARLOTTE SQUARE,EDINBURGH,MIDLOTHIAN,EH2 4DF

Key Metrics

Founded Year

2001

Location

Yavne, Israel

Stage

Public

Total Funding

$18M in 6 rounds

Latest Funding Round

Grant (prize money), Jul 16, 2024, $*****

Investors

Point72 & 11 more

Ranked

6^th among 206 active competitors

Employee Count

119 as on May 31, 2026

Investment & Acquisitions

PolyHeal

Similar Companies

SolasCure & 239 more

Exit Details

Public

View MediWound's full profile

MediWound is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MEDIWOUND UK LIMITED CIN: SC271137 , United Kingdom, Active	Jul 25, 2004	-	-
Mediwound Ltd. CIN: 1593984 , United States, Active		$5M - $25M (As on Oct 06, 2022)	-	-

MediWound got listed on Mar 20, 2014.

Click here to take a look at MediWound's IPO in detail

MediWound has raised a total funding of $18M over 6 rounds. Its first funding round was on Jun 23, 2013. Its latest funding round was a Grant (prize money) round on Jul 16, 2024 for $*****. 1 investor participated in its latest round. MediWound has 10 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of MediWound:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 16, 2024	1973840	Grant (prize money)	7784943	2139873	2312964	9367318
Dec 28, 2023	6753844	Grant (prize money)	4879272	2967166	5902724	MTEC
Feb 05, 2023	7733008	Post IPO	3984032	9130462	8186277	Point72 & 5 more

Access funding benchmarks and valuations. Sign up today!

View details of MediWound's funding rounds and investors

MediWound's employee count trend

MediWound has 119 employees as of May 26. Here is MediWound's employee count trend over the years:

Uncover MediWound's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MediWound include SolasCure, SanuWave and Nuo Therapeutics. Here is the list of Top 10 competitors of MediWound, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	SolasCure 2017, Cambridge (United Kingdom), Series B	Developer of biologic therapies for the treatment of chronic wounds	$34.1M	Seneca, Tricor Group & 66 others	62/100
2nd	SanuWave 2005, Alpharetta (United States), Public	Developer of Noninvasive devices, and biologics for wound healing	$1.43M	CIT, Kingswood Capital Markets	60/100
3rd	Nuo Therapeutics 2001, Gaithersburg (United States), Public	Developer of regenerative products for wound care	$69.1M	MidCap Financial, Maryland Department of Commerce ... & 2 others	57/100
4th	Sanara MedTech 1982, Fort Worth (United States), Public	Developer of therapeutics for infectious disease	-	BlueIO, The Catalyst Group	56/100
5th	TargED 2020, Utrecht (Netherlands), Series A	Developer of biological drugs for the treatment of thrombosis	$82.8M	Andera Partners, Sunstone & 8 others	56/100
6th	MediWound 2001, Yavne (Israel), Public	Developer of enzymatic therapeutic solutions for tissue repair and regeneration	$18M	Point72, New Era Capital Partners & 10 others	54/100
7th	Tissue Regenix 2006, Swillington (United Kingdom), Public	Developer of regenerative medical devices by using cell technology	-	Harwood Capital, Aquarius Equity Partners ... & 2 others	53/100
8th	QBiotics 2000, Brisbane (Australia), Series C	Developer of small molecules discovered from the plant extracts	$98.1M	TDM Growth Partners, WG Partners	53/100
9th	Next Science 2012, Jacksonville (United States), Public	Redefining healing through science, innovation, and commitment to better patient outcomes	-	-	51/100
10th	BioStem Technologies 2006, Pompano Beach (United States), Public	Provider of placental-based amniotic tissue products	-	-	51/100